Cytrx Corp., of Los Angeles, began operations at its discovery laboratory in Freiburg, Germany. The laboratory will conduct discovery and translational research to create drug candidates that use linker technologies to couple chemotherapeutic agents and proteins inside or outside the body to be concentrated in tumors.